Literature DB >> 8549088

Prognostic factors for the outcome of methotrexate treatment in rheumatoid arthritis.

G Kolarz1, F Mayrhofer, P Peichl, E Posch, O Scherak, F Singer, N Thumb, A Wottawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549088     DOI： 10.1007/bf02208147

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  12 in total

1.  Methotrexate in rheumatoid arthritis.

Authors:  D E Furst; J M Kremer
Journal:  Arthritis Rheum       Date:  1988-03

2.  The effects of methotrexate on soluble interleukin-2 receptor levels in rheumatoid arthritis: comment on the article by Barrera et al.

Authors:  A Crilly; R Madhok
Journal:  Arthritis Rheum       Date:  1994-04

3.  Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.

Authors:  R P Polisson; M A Dooley; D V Dawson; D S Pisetsky
Journal:  Arthritis Rheum       Date:  1994-01

4.  Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study.

Authors:  M H Arnold; J O'Callaghan; M McCredie; E M Beller; D E Kelly; P M Brooks
Journal:  Br J Rheumatol       Date:  1990-04

5.  Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.

Authors:  P S Hanrahan; G A Scrivens; A S Russell
Journal:  Br J Rheumatol       Date:  1989-04

6.  Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis.

Authors:  P Peichl; M Ceska; H Broell; F Effenberger; I J Lindley
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

7.  Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis.

Authors:  P Peichl; M Ceska; F Effenberger; G Haberhauer; H Broell; I J Lindley
Journal:  Scand J Immunol       Date:  1991-09       Impact factor: 3.487

8.  Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.

Authors:  P Barrera; A M Boerbooms; E M Janssen; R W Sauerwein; H Gallati; J Mulder; T de Boo; P N Demacker; L B van de Putte; J W van der Meer
Journal:  Arthritis Rheum       Date:  1993-08

9.  Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases.

Authors:  J Sany; J M Anaya; V Lussiez; M Couret; B Combe; J P Daures
Journal:  J Rheumatol       Date:  1991-09       Impact factor: 4.666

10.  Analysis of methotrexate treatment effect in a longitudinal observational study: utility of cluster analysis.

Authors:  F Wolfe; M A Cathey
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.